Whalerock Point Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.38M Hold
2,585
0.46% 45
2025
Q4
$2.78M Sell
2,585
-175
-6% -$167K 0.53% 41
2025
Q3
$2.11M Hold
2,760
0.43% 44
2025
Q2
$2.15M Buy
2,760
+57
+2% +$44.3K 0.47% 45
2025
Q1
$2.23M Hold
2,703
0.53% 44
2024
Q4
$2.09M Buy
2,703
+25
+0.9% +$20.7K 0.49% 42
2024
Q3
$2.37M Buy
2,678
+860
+47% +$773K 0.56% 41
2024
Q2
$1.65M Buy
1,818
+155
+9% +$124K 0.44% 46
2024
Q1
$1.29M Hold
1,663
0.35% 55
2023
Q4
$969K Buy
1,663
+180
+12% +$105K 0.3% 62
2023
Q3
$797K Hold
1,483
0.28% 65
2023
Q2
$695K Buy
1,483
+89
+6% +$37.3K 0.24% 73
2023
Q1
$479K Hold
1,394
0.18% 82
2022
Q4
$510K Hold
1,394
0.21% 76
2022
Q3
$451K Hold
1,394
0.2% 78
2022
Q2
$452K Buy
1,394
+30
+2% +$9.01K 0.19% 81
2022
Q1
$391K Hold
1,364
0.14% 101
2021
Q4
$377K Hold
1,364
0.13% 106
2021
Q3
$315K Hold
1,364
0.12% 107
2021
Q2
$313K Hold
1,364
0.12% 112
2021
Q1
$255K Hold
1,364
0.11% 115
2020
Q4
$230K Buy
1,364
+1,162
+575% +$173K 0.11% 117
2020
Q3
$202K Sell
202
-1,162
-85% -$180K 0.11% 116
2020
Q2
$224K Buy
+1,364
New +$209K 0.13% 106

Other funds holding LLY

Whalerock Point Partners's LLY Position: Q1 2026 in Review

Whalerock Point Partners held its Eli Lilly (LLY) position steady in Q1 2026 at 2,585 shares worth $2.38M. The position accounts for 0.46% of the portfolio, ranked #45.

Whalerock Point Partners first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.78M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Whalerock Point Partners held 2,585 shares of Eli Lilly worth $2.38M as of Q1 2026.
  • Whalerock Point Partners left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.46% of Whalerock Point Partners's portfolio in Q1 2026, its #45 holding.
  • Whalerock Point Partners first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
  • Whalerock Point Partners's Eli Lilly position peaked at $2.78M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Whalerock Point Partners's 13F filing for Q1 2026, filed 15 May 2026.